Please login to the form below

Not currently logged in
Email:
Password:

The Carlyle Group

This page shows the latest The Carlyle Group news and features for those working in and with pharma, biotech and healthcare.

British officials reportedly monitoring Philip Morris’ proposed acquisition of Vectura

British officials reportedly monitoring Philip Morris’ proposed acquisition of Vectura

Vectura, which is developing inhaled drug delivery solutions for a number of diseases – including COVID-19 – previously received another acquisition offer from private equity group Carlyle in May. ... However, the company’s board has withdrawn

Latest news

  • Philip Morris International to acquire inhaled drug company Vectura for $1.2bn Philip Morris International to acquire inhaled drug company Vectura for $1.2bn

    Vectura, which is developing inhaled drug delivery solutions for a number of diseases – including COVID-19 – previously received another acquisition offer from private equity group Carlyle in May. ... However, the company’s board has withdrawn

  • The M&A trend in pharma The M&A trend in pharma

    By moving the domicile of the (new) parent company of the group, the tax that would otherwise be payable on overseas profits under 'controlled foreign company' rules can be reduced. ... Following the Carlyle Group's $4bn acquisition of Johnson and Johnson

  • J&J sells diagnostics unit to private equity firm J&J sells diagnostics unit to private equity firm

    Ortho-Clinical Diagnostics acquired by the Carlyle Group. Johnson &Johnson has agreed to sell its clinical diagnostics business to private equity firm Carlyle Group for $4.15bn as it continues to ... Carlyle is reported to have been one of three

  • The Carlyle Group appoints Essner

    The Carlyle Group, a global private equity firm, has appointed former Wyeth CEO,  Robert Essner,  as senior advisor to its global healthcare group. ... The Carlyle Group, a global private equity firm, has appointed Robert Essner, former CEO and

More from news
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest Intelligence

  • Pharma deals during March 2014 Pharma deals during March 2014

    On the last day of the month Johnson &Johnson (J&J) agreed to accept the $4bn offer from The Carlyle Group, which was originally announced in January, to acquire its ... Large pharma activity. Several of the large pharma announced strategic transactions

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
M3 (EU)

M3 is the world’s largest network of verified doctors with over 6 million members across key markets; our closed and...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...